United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Oct 6, 2026 · Filed Oct 7, 2026

On Oct 6, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$538.67 for US$5.12M under a trading plan, leaving 324,443 shares. Filed Oct 7, 2026 (Form 4).

Sold
9,500 shares
Price
US$538.67 average (US$527.90 to US$545.50)
Value
US$5.12M
Holding after
324,443 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Oct 6, 2026Common StockOption exercise9,500US$117.76333,943Indirect
Oct 6, 2026Common StockSale280US$527.90333,663Indirect
Oct 6, 2026Common StockSale360US$528.72333,303Indirect
Oct 6, 2026Common StockSale240US$530.13333,063Indirect
Oct 6, 2026Common StockSale320US$531.94332,743Indirect
Oct 6, 2026Common StockSale215US$533.14332,528Indirect
Oct 6, 2026Common StockSale167US$534.30332,361Indirect
Oct 6, 2026Common StockSale734US$535.71331,627Indirect
Oct 6, 2026Common StockSale323US$536.25331,304Indirect
Oct 6, 2026Common StockSale133US$537.58331,171Indirect
Oct 6, 2026Common StockSale1,088US$538.61330,083Indirect
Oct 6, 2026Common StockSale1,606US$539.68328,477Indirect
Oct 6, 2026Common StockSale2,054US$540.68326,423Indirect
Oct 6, 2026Common StockSale380US$541.55326,043Indirect
Oct 6, 2026Common StockSale120US$542.49325,923Indirect
Oct 6, 2026Common StockSale558US$543.99325,365Indirect
Oct 6, 2026Common StockSale842US$544.75324,523Indirect
Oct 6, 2026Common StockSale80US$545.50324,443Indirect

Source

View original at SEC

Related